The escalation of maternal obesity presents an unprecedented challenge to global reproductive health, complicating clinical management and stretching healthcare resources. This research is highly relevant as it provides contemporary, prospective data on the magnitude of risk associated with high maternal BMI, moving beyond retrospective databases. Understanding the specific risk profiles—ranging from increased surgical interventions to systemic metabolic complications—allows for the development of targeted clinical pathways. In an era of precision medicine, identifying the exact correlation between adiposity and placental-mediated diseases like preeclampsia is essential for improving maternal morbidity and mortality rates. This study serves as a call to action for policymakers and clinicians to integrate metabolic health into routine reproductive care. The findings support the implementation of more rigorous screening protocols and specialized labor management strategies for obese parturients, ultimately aiming to reduce the long-term sequelae of obesity-related birth complications on the pediatric population.
The primary aim of this study was to quantify the association between maternal obesity (BMI ≥30 kg/m²) and the risk of adverse maternal and neonatal outcomes compared to normal-weight counterparts in a prospective cohort.
This prospective cohort study enrolled 740 singleton pregnancies between August 2021 and December 2023 at a tertiary referral center. Participants were categorized based on WHO BMI criteria: Normal weight (18.5–24.9 kg/m², n=310), Overweight (25.0–29.9 kg/m², n=245), and Obese (≥30.0 kg/m², n=185). Exclusion criteria included pre-existing diabetes, chronic hypertension, and multiple gestations. Primary outcomes measured were GDM (75g OGTT at 24-28 weeks), HDP, and delivery mode. Secondary outcomes included birth weight, Apgar scores, and NICU admission rates. Statistical analysis was performed using SPSS v26, employing Chi-square tests for categorical variables and multivariate logistic regression to calculate adjusted Odds Ratios (aOR) with 95% Confidence Intervals (CI), adjusting for maternal age, parity, and socioeconomic status. Significance was defined at p
4000g) was 14.6% in the obese cohort versus 3.2% in the control group (aOR 4.9; 95% CI 2.1–11.2). NICU admissions were significantly more frequent for neonates of obese mothers (12.4% vs. 4.5%, p=0.003), primarily due to respiratory distress and hypoglycemia. Logistic regression confirmed that for every 5-unit increase in pre-pregnancy BMI, the risk of composite maternal morbidity increased by 28% (aOR 1.28; 95% CI 1.15–1.42).
Maternal obesity acts as a significant independent risk factor for a spectrum of adverse pregnancy outcomes, characterized by metabolic dysregulation and increased obstetric intervention. The linear correlation between BMI and complications like GDM and preeclampsia suggests that even modest reductions in pre-pregnancy weight could yield substantial improvements in maternal health. The elevated rate of cesarean deliveries and NICU admissions reinforces the economic and clinical burden of obesity on healthcare systems. These findings advocate for a shift toward preventative reproductive medicine, emphasizing pre-conceptional counseling and multidisciplinary antenatal care. Future research should focus on the efficacy of specific lifestyle interventions during the first trimester to interrupt the pathophysiological pathways linking adiposity to placental dysfunction and fetal overgrowth. Addressing maternal obesity is no longer optional but a central pillar of modern obstetric excellence.